Date post: | 27-Dec-2015 |
Category: |
Documents |
Upload: | chikezie-onwukwe |
View: | 12 times |
Download: | 2 times |
LUPUS NEPHRITIS:AN UNDERDIAGNOSED CONDITION?
Dr Femi Adelowo, M.B.B.S(Ib), FMCP, FWACP, FACR, FRCP(Edin) FRCP(Lond)
Professor of Medicine/Consultant Rheumatologist Lagos University College of Med/LASUTH and Arthrimed Specialist Clinic Ikeja
INTRODUCTION
What manner of disease is Systemic Lupus Erythematosus (SLE)?
Multisystemic auto immune disease affecting mostly females
Incidence estimate – 1.8 – 7.6 cases per 100,000 person years – (USA) [1]
INTRODUCTION
3.3 – 4.8 per 100,00 person years (Europe) – [2] Few case reports from Africa Said to be rare – [3] Recent reports show that is not uncommon Constitutes 5.25% of rheumatological cases – [4]
– Fessel W. J. Arch. Int. Med 1974; 134: 1027-35– Gudnundsson S, Steinsson K. J. Rheumatol. 1990:17:1162-1167– Bae SC et al. Arthritis Rheum. 1999:41:2091-2099– Adelowo O. O, Oguntona S. Clin Rheumatol 2009: 28:6:699-703– Adelowo O. O, Bamgboye E L. Lupus Nephritis among Nigerians: Case Reports and Literature Review. In
EAMJ
PRESENTATION
Recurrent fever(Malaria-Typhoid-Malaria Syndrome!!), polyarthralgia, weight loss, extreme fatigue, loss of weight, seizures
Diagnosis by ACR criteria- Malar rash Discoid rash Photosensitivity
ACR CRITERIA
Non erosive arthritis Pleuritis or pericarditis Renal disorders Seizures or psychosis Hematologic disorder .Immunological disorder – anti DNA, Anti
Sm, ACA, false +ve VDRL Positive ANA
– FREQUENCY OF LUPUS NEPHRITIS
Very high among African Americans [1] Low prevalence among black Africans –[2] Prevalence may be high in black Africans Report of urinary abnormalities in 35 out of 44 –
Nigerian series – [3] Report from Dakar, Senegal – 13% with Histological features of lupus nephritis in a non
selective series of 115 kidney biopsies – [4]
CONTD
– 1.Tang S et al. Nephrology 2005; 10(2): 174-179– 2.McCarty D J et al. Arthritis Rheum: 38: 1260-70– 3.Adelowo O O, Oguntona S. Clin. Rheumatol 2009;28:699-703– 4.Diouf B et al. Dakar Med 2001:46(1):51-3
Kidney affectation is of prognostic importance 60% of Adults and 80% of SLE develop Lupus
Nephritis:STUDY OF 12,344 of ESRD from LN(1995-2006)
10-30% develop ESRD within 15 years
49.5% were blacks SLE and Lupus Nephritis commoner in
blacks
Costenbader KH. Arth Rheum on line Mar 28
SIGNS OF LUPUS NEPHRITIS– Nocturia( tubular dysfunction)– Foamy urine( glomerular dysfunction)– Nephrotic syndrome( 20%: oedema)– Hypertension
DIAGNOSIS
How is Lupus Nephritis diagnosed? Combination of clinical, laboratory and
possible biopsy results 24 hour proteinuria of more than 500mg or
Dipstick of 3+ Presence of casts (red blood cell, heme,
granular, tubular, mixed
Haematuria Pyuria in absence of infection Elevated creatinine
Ref. Rahman P et al. Lupus 2001:10:418-423
EARLY DETECTION CRITICAL– Regular urine analysis– Early morning concentrated urine– Microscopic examination– Regular assessment of proteinuria– Regular assessment of renal function
PROTEINURIA– Dipstick for screening purposes only– 24 hour proteinuria: timed urine collection often
inadequate(30% under-collection: 15% over-collection
– Urine protein-to-creatinine ratio preferred to creatinine clearance
MICROSCOPIC URINE ANALYSIS– Not during menstrual periods– Immediate processing of specimen(bacterial
overgrowth makes urine alkaline/disrupts casts– RBC morphology critical-dysmorphism glomerular
origin– WBCs, RBCs,mixed casts-
nephritic(inflammatory)– Granular/fatty casts- proteinuric states
HISTOLOGY
Renal biopsy controversial but perform if significant proteinuria
WHO classified based on changes on light, electron microscopy and immunofluorescence –
Class I – Normal histology on light, electron microscopy, immunoflourescence
Class II – Mesangial expansion and immune deposits Class III – Focal proliferative Class IV Diffuse Proliferative Class V – Membranous Class VI – Glomerulosclerosis
Golbus J, McCune W J. Rheum Dis North Am 1994;20:213-242
PROGNOSTIC FACTORS FOR ESRD– African American race– Poor socio economic status– Non compliance with medications– Severe clinical onset– Uncontrolled hypertension– Renal relapse– Poor initial response to therapy
TREATMENT
What is the treatment? Time is of essence especially among
Nigerians Delay will result in CKD Dialysis is mostly unaffordable or unavailable
in Nigeria Early immunosuppressive treatment critical Initiation
TREATMENT
1. NIH regimen:INITIATION Pulse IV .Cyclophosphamide – High dose Igm monthly X 6 months
MAINTENANCE 1GM three monthly to 2 years 2. EULAR REGIMEN : INITIATION Pulse IV Cyclophosphamide
Low Dose 500mg every 2 weeks X 3 Months MAINTENANCE- Azathioprine tablets( 1-2mg/Kg) Mycophenolate Mofetil
3 Mycophenolale Mofetil for both induction and maintenance
4. Rituximab+/- Cyclophosphamide- Induction. Maintenance- Azathioprine or Mycophenolate
– Maintenance – Azathioprine or Mycophenolate Mofetil or Leflunomide
– Pulse Methylprednisolone– Oral Corticosteroids
Rituximab in organ involvement of SLE CLINICAL RESPONSES( 188 SLE patients) Cardiopulmonary- 100% Haematological- 94% Renal 91% Articular 91% CNS 89% Mucocutaneous 89%
Rituximab and organs response contd(%)
Epilepsy 100 Type V nephropathy 100 Type IV nephropathy 98 Serositis 87 Type III nephropathy 82 Pericarditis 50
Ramos-Casals M, Soto MJ, Cuadrado MJ et. al Lupus 2009, 18: 767-776
PROGNOSIS
What is the prognosis? Good if immunosuppressives are
introduced early.Supportive management- renal replacement therapy
Adelowo O. O, Bamgboye E L. Lupus Nephritis among Nigerians: Case reports and Literature Review – EAMJ